Comments
Loading...
BioLine Rx Earnings Estimates, EPS & Revenue | NASDAQ:BLRX | Benzinga
BioLine Rx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS Estimate
$-1.20
Quarterly Revenue Estimate
$924.00K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$22.34M
Analyze the earnings history of BioLine Rx using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLRX | BioLine Rx | $0.00 | -$1.20 | — | — | $5.39M | $924.00K | — | — | 08/14/2025 | Get Alert |
| BLRX | BioLine Rx | -$0.01 | -$1.20 | $0.00 | 100.09% | $6.86M | $792.00K | $255.00K | -82.77% | 05/27/2025 | Get Alert |
| BLRX | BioLine Rx | -$0.15 | -$0.93 | $0.00 | — | $4.80M | $7.72M | $11.75M | 52.19% | 03/31/2025 | Get Alert |
| BLRX | BioLine Rx | -$0.26 | -$0.05 | -$0.07 | 30.00% | $0.00 | $5.29M | $4.94M | 19.98% | 11/25/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.30 | -$0.14 | $0.00 | 100.00% | $0.00 | $3.93M | $5.39M | 37.23% | 08/15/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.10 | -$0.29 | -$0.01 | 96.55% | $0.00 | — | $6.86M | — | 05/28/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.08 | -$0.22 | -$0.15 | — | $0.00 | — | $4.80M | — | 03/26/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | -$0.21 | -$0.26 | -23.81% | $0.00 | — | $0.00 | — | 11/20/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | — | -$0.30 | — | $0.00 | — | $0.00 | — | 08/30/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.10 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 05/24/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.18 | -$0.14 | -$0.08 | 42.86% | $0.00 | — | $0.00 | — | 03/22/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.01 | -$0.11 | -$0.15 | -36.36% | $0.00 | — | $0.00 | — | 11/15/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.15 | -$0.07 | -$0.15 | -114.29% | $0.00 | — | $0.00 | — | 08/16/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | -$0.15 | -$0.10 | 33.33% | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.14 | -$0.18 | -28.57% | $0.00 | — | $0.00 | — | 03/16/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.30 | -$0.16 | -$0.15 | 6.25% | $0.00 | — | $0.00 | — | 11/18/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.45 | -$0.15 | -$0.15 | 0.00% | $0.00 | — | $0.00 | — | 08/18/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.15 | -$0.30 | -100.00% | $0.00 | — | $0.00 | — | 05/26/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.90 | -$0.27 | -$0.60 | -122.22% | $0.00 | — | $0.00 | — | 02/23/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.45 | -$0.35 | -$0.30 | 14.29% | $0.00 | — | $0.00 | — | 11/23/2020 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.73 | -$0.45 | 38.36% | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
BioLine Rx (BLRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-27 | $0 | $-1.20 | 100.1 % |
| Q3 | 2024-11-25 | $-0.07 | $-0.05 | 30.0 % |
| Q2 | 2024-08-15 | $0 | $-0.14 | 100.0 % |
| Q1 | 2024-05-28 | $-0.01 | $-0.29 | 96.5 % |
BioLine Rx (BLRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-27 | $255.00K | $792.00K | -82.8 % |
| Q4 | 2025-03-31 | $11.75M | $7.72M | 52.2 % |
| Q3 | 2024-11-25 | $4.94M | $5.29M | 20.0 % |
| Q2 | 2024-08-15 | $5.39M | $3.93M | 37.2 % |
FAQ
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx (BLRX) is scheduled to report earnings on August 14, 2025. The last reported earnings were for reported on May 27, 2025 for Q1.
What were the latest earnings per share (EPS) for BioLine Rx (NASDAQ:BLRX)?
The Actual EPS was $0.00, which beat the estimate of $-1.20.
What were BioLine Rx’s (NASDAQ:BLRX) revenues?
The Actual Revenue was $255K, which missed the estimate of $792K.
Browse earnings estimates, EPS, and revenue on all stocks.
